Biocon Biologics Inc

1 products tracked · names used in filings: Biocon Biologics Inc

Upcoming milestones

No upcoming milestones listed.

Recent milestones

Thu 12 Nov 2026🇺🇸 FDA approval

FDA approves Pebrilzo (pertuzumab), a new medicine

Biocon Biologics Inc; BLA761501; New biologic; solution · source

Products

ProductStatusApproved
🇺🇸Pebrilzo
pertuzumab
Approved2026-11-12

Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.